Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
SW Thames Renal & Transplantation Unit, St. Helier Hospital, Surrey, UK. peter.andrews@esth.nhs.uk
The third edition of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease after Solid Organ Transplantation was published in March 2011. This article summarizes the important changes and advances in management in this rapidly evolving field. The pros and cons of universal, or targeted anti-cytomegalovirus (CMV) prophylaxis, and pre-emptive anti-CMV therapy are discussed, especially with respect to advances in CMV polymerase chain reaction monitoring. The evidence for oral anti-CMV prophylaxis using valganciclovir is presented, together with a summary of the treatment of CMV disease and emerging fields such as CMV vaccination, CMV genotyping, and drug resistance.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on